UZD

United States Cellular Corporat (UZD) 10Y Growth Potential Analysis (2026)

Invetso Score: 5.6/10 — Balanced · Last Updated: 2026-08-01

Revenue Growth Drivers

Revenue growth capacity appears moderate because 5-year CAGR data is unavailable, while TTM profitability and leverage suggest operating stability rather than proven compounding versus peers.

Return on invested capital of 11.7% supports some reinvestment-driven expansion, but it remains below stronger compounders that typically sustain higher incremental returns over time.

Negative free cash flow yield and high capex intensity indicate growth requires heavy reinvestment, which can support expansion but reduces self-funded scaling versus peers.

Interest coverage of 10.5x and net debt to EBITDA of 0.88x preserve financing flexibility, yet they do not by themselves demonstrate superior long-term revenue compounding.

Market Tailwinds

No direct evidence of durable demand acceleration is provided, so market tailwinds cannot be scored above peers with documented multi-year growth catalysts.

The absence of segment concentration data limits proof of exposure to faster-growing end markets, leaving growth support less visible than for more diversified peers.

A negative cash conversion cycle of -88.6 days can aid working-capital efficiency, but it is an execution benefit rather than a structural demand tailwind.

Compared with peers showing explicit secular demand exposure, UZD’s tailwind profile is more muted because the available metrics emphasize financial efficiency over market expansion.

Scalability Expansion

Scalability is moderate because the business converts capital into returns, but the 46.9% capex-to-revenue ratio implies expansion remains asset-intensive versus lighter-model peers.

Negative cash conversion cycle improves internal funding of growth, which supports scaling, although it does not offset the capital burden of expansion.

Low net leverage and strong interest coverage provide room to reinvest or fund capacity growth, but the metrics do not show exceptional operating leverage.

Relative to high-scalability peers, UZD appears capable of steady expansion, yet the current capital intensity suggests slower compounding and lower incremental scalability.

Constraints Limitations

High capex intensity is the main structural constraint because it ties growth to ongoing asset investment, limiting the speed of revenue compounding versus asset-light peers.

The lack of disclosed 5-year growth history reduces confidence in durable scaling, making it harder to evidence repeatable expansion across cycles.

Negative free cash flow yield suggests current growth is not yet translating into surplus cash, which can constrain reinvestment flexibility relative to stronger peers.

No segmentation or concentration data is available, so potential dependence on narrower revenue streams cannot be ruled out as a long-term scaling limit.

Overall Score

UZD shows moderate long-term growth capacity: reinvestment support and balance-sheet flexibility exist, but heavy capital intensity and limited proof of durable compounding cap peer-relative upside.

Score Driver: Capital Intensive Expansion

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on United States Cellular Corporat. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →